Cellmark India Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 1.17 Cr
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 0.86%
- Profit Growth -4276.89%
- Ebitda -3918.34%
- Net Worth -2996.96%
- Total Assets 58.11%
About Cellmark India
Cellmark India Private Limited (CIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 02 December 2008 and has a history of 16 years and two months. Its registered office is in Nagpur, Maharashtra, India.
The Corporate was formerly known as Alcan International Network India Private Limited. The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ajay Aloni, Ersin Alkan, and Jan Jonsson serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72900MH2008FTC188578
- Company No.
188578
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
02 Dec 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Cellmark India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Aloni  | Managing Director | 31-Mar-2021 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ersin Alkan  | Director | 08-May-2021 | Current |
Jan Jonsson  | Director | 02-May-2023 | Current |
Financial Performance of Cellmark India.
Cellmark India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.86% increase. The company also saw a substantial fall in profitability, with a 4276.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2996.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cellmark India?
In 2023, Cellmark India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chemiker Pharmaceuticals Private LimitedAjay Aloni is a mutual person
Toolika Commercials Private LimitedAjay Aloni is a mutual person
- Asmivilla Hospitality Private Limited
Ajay Aloni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cellmark India?
Unlock and access historical data on people associated with Cellmark India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cellmark India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellmark India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
